1
|
Li J, Zhang G, Liu T, Gu H, Yan L, Chen B. Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects. Exp Ther Med 2012. [PMID: 23181115 PMCID: PMC3503886 DOI: 10.3892/etm.2012.613] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
This study aimed to construct a novel recombinant expression vector, pcDNA3.1(-)hTERT-shRNA/yCDglyTK. Its bioactivity and antitumor effects were investigated in the SGC7901 human gastric cancer cell line. Interfering RNA (RNAi) targeting human telomerase reverse transcriptase (hTERT) was applied to construct the pYr1.1-hTERT-shRNA vector. The shRNA expression cassette (including U6 promoter) was subcloned into the pcDNA3.1(-) CV-yCDglyTK vector to build a new vector, pcDNA3.1(-) hTERT-shRNA/yCDglyTK, which was identified by restriction enzyme digestion and gene sequencing. All the plasmids were delivered into SGC7901 cells using calcium phosphate nanoparticles (CPNPs). Expression of yCDglyTK and hTERT was detected by immunofluorescence, real-time PCR and western blot analysis. MTT assays were applied to measure the cytotoxic effect of the plasmids with 5-fluorocytosine (5-FC). Cell apoptosis was detected by flow cytometry. Restriction enzyme digestion and gene sequencing confirmed that the recombinant vector pcDNA3.1(-)hTERT-shRNA/yCDglyTK had been successfully constructed. Immunofluorescence, real-time PCR and western blot analysis showed that yCDglyTK was expressed, and that hTERT expression was inhibited in cells transfected with the recombinant vector. The cells transfected with the recombinant vector were the most sensitive to 5-FC and the apoptosis rates of the cells were also increased. The pcDNA3.1(-)hTERTshRNA/yCDglyTK vector was constructed successfully; it was confirmed that targeting hTERT through RNAi could synergize with suicide gene therapy.
Collapse
Affiliation(s)
- Jia Li
- Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
| | | | | | | | | | | |
Collapse
|
2
|
Khalighinejad N, Hariri H, Behnamfar O, Yousefi A, Momeni A. Adenoviral gene therapy in gastric cancer: A review. World J Gastroenterol 2008; 14:180-4. [PMID: 18186552 PMCID: PMC2675111 DOI: 10.3748/wjg.14.180] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Gastric cancer is one of the most common malignancies worldwide. With current therapeutic approaches the prognosis of gastric cancer is very poor, as gastric cancer accounts for the second most common cause of death in cancer related deaths. Gastric cancer like almost all other cancers has a molecular genetic basis which relies on disruption in normal cellular regulatory mechanisms regarding cell growth, apoptosis and cell division. Thus novel therapeutic approaches such as gene therapy promise to become the alternative choice of treatment in gastric cancer. In gene therapy, suicide genes, tumor suppressor genes and anti-angiogenesis genes among many others are introduced to cancer cells via vectors. Some of the vectors widely used in gene therapy are Adenoviral vectors. This review provides an update of the new developments in adenoviral cancer gene therapy including strategies for inducing apoptosis, inhibiting metastasis and targeting the cancer cells.
Collapse
|
3
|
Huang CH, Ou-Yang L, Ma HH, Tang ZH, Li G, Yao JL. Construction of replication-deficient recombinant adenoviral vector carrying HBV S and C region gene by homologous recombination in bacteria and its expression in vitro. Shijie Huaren Xiaohua Zazhi 2003; 11:438-441. [DOI: 10.11569/wcjd.v11.i4.438] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM To construct recombinant adenoviral vector carrying HBV S and C region gene by homologous recombination in bacteria and to detect its expression in vitro.
METHODS HBV pre-S2/S genes and pre-C/C genes were amplified by PCR and were cloned to adenoviral shuttle plasmid pAdTrack-CMV, respectively. Then the resultant pAd Track-CMV-HBs or pAdTrack-CMV-HBe was cotransfected into BJ5183 bacteria with the plasmid pAdeasy-1. The adenoviral plasmid carrying HBV S and C gene (pAd-HBs and pAd-HBe) was generated with homologous recombination in bacteria and the adenoviruses were produced in 293 cells. Both 293 and Vero cells were infected with adenoviruses and the expression of HBsAg and HBeAg was detected by RT-PCR and ELISA in vitro.
RESULTS The titer of Ad-HBs and Ad-HBe adenoviruses was up to 5×1012 pfu/L after proliferation in 293 cells. HBsAg and HBeAg were expressed efficiently in 293 and Vero cells after infection.
CONCLUSION The recombinant adenoviruses expressing HBsAg or HBeAg were constructed successfully and can be used further in gene therapy of HBV.
Collapse
Affiliation(s)
- Cheng-Hui Huang
- Department of Infectious Diseases, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, Guangdong Province, China
| | - Ling Ou-Yang
- Shenzhen Baoan Blood Center, Shenzhen 518101, Guangdong Province, China
| | - Hui-Hui Ma
- Department of Infectious Diseases, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, Guangdong Province, China
| | - Zheng-Hao Tang
- Department of Infectious Diseases, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, Guangdong Province, China
| | - Gong Li
- Department of Infectious Diseases, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, Guangdong Province, China
| | - Ji-Lu Yao
- Department of Infectious Diseases, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, Guangdong Province, China
| |
Collapse
|
4
|
Li LS, Qu RY, Wang W, Guo H. Significance of changes of gastrointestinal peptides in blood and ileum of experimental spleen deficiency rats. World J Gastroenterol 2003; 9:553-6. [PMID: 12632517 PMCID: PMC4621581 DOI: 10.3748/wjg.v9.i3.553] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To explore the mechanism of spleen deficiency (SD) by studying the relationship of gastro-intestinal peptides level and ileal electro-mechanical activity of SD rats and cold restrain rats.
METHODS: (1) spleen deficiency (SD) model was established by feeding Houpou:Zhishi: Dahuang in the ratio of 3:3:2, 3 ml/time, for 42 days. (2) The cold restrain stress model: Animals were restrained on grille and placed in a cool water at 18 °C for 3 h. (3) Substance P (SP) and vasoactive intestinal peptide (VIP) levels in all layers of initial part of ileum and blood in rats were measured by radioimmunoassays (RIA) while changes of electric activity and motility in ileum of rats were recorded with electrode and strain gauge.
RESULTS: SP levels in ileum and blood of experimental SD rats were significantly higher than that of the control groups (9.89 ± 5.65 vs 1.22 ± 1.18, P < 0.005, in ileum; 22.7 ± 3.95 vs 6.60 ± 1.47, P < 0.001, in blood) while the VIP levels of the SD rats were significantly lower than that of the controls (3.50 ± 2.01 vs 9.10 ± 4.91, P < 0.05, in ileum; 229.8 ± 62.4 vs 560.4 ± 151.3, P < 0.001, in blood). As compared with the controls, the average frequency of slow electric waves (21.3 ± 0.96 vs 18.2 ± 2.28, P < 0.05) and motility (21.5 ± 0.58 vs 18 ± 2.65, P < 0.005) of SD rats increased obviously and the frequency of fast waves of SD rat also increased. In spontaneous recovery cases, SP levels recovered significantly (compared with the SD groups, 2.99 ± 0.62 vs 9.89 ± 5.65, P < 0.001, in ileum; 14.4 ± 4.22 vs 22.7 ± 3.95, P < 0.001, in blood) but did not drop to normal. After the SD rats treated with Chinese herbs (Jiawei Sijun zi Tang), SP improved (compared with SD cases, 2.20 ± 1.25 vs 9.89 ± 5.65, (P < 0.001), in ileum; 10.7 ± 1.88 vs 22.7 ± 3.95, (P < 0.001), in blood) and VIP in blood also improved (compared with SD rats, 485.7 ± 229.0 vs 229.8 ± 62.4, P < 0.01) while the amplitude of motility decreased apparently (compared with the SD rats, 0.64 ± 0.096 vs 0.89 ± 0.15, P < 0.01). The ileal SP levels of cool stress didn’t change while the ileal VIP levels of cool stress became significantly lower than that of the control groups (2.87 ± 0.87 vs 9.10 ± 4.91, P < 0.01). The blood SP levels of cool stress were significantly higher (15.60 ± 1.83 vs 6.60 ± 1.47, P < 0.001) whereas the blood VIP levels of cool stress were significantly lower than that of the control group (153.4 ± 70.46 vs 560.4 ± 151.30, P < 0.001).
CONCLUSION: Changes of SP and VIP levels in initial part of ileum and blood of SD rats and cool stress rats may be closely related to the gastrointestinal motility disorders presented in SD and cool stress rats. the Chinese herbs (Jiawei Sijun zi Tang) currently used have partially therapeutic effect.
Collapse
Affiliation(s)
- Li-Sheng Li
- Department of Physiology, Capital University of Medical Sciences, 100054, Beijing, China.
| | | | | | | |
Collapse
|
5
|
Ma CH, Sun WS, Tian PK, Gao LF, Liu SX, Wang XY, Zhang LN, Cao YL, Han LH, Liang XH. A novel HBV antisense RNA gene delivery system targeting hepatocellular carcinoma. World J Gastroenterol 2003; 9:463-7. [PMID: 12632498 PMCID: PMC4621562 DOI: 10.3748/wjg.v9.i3.463] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2002] [Revised: 08/23/2002] [Accepted: 09/04/2002] [Indexed: 02/06/2023] Open
Abstract
AIM To construct a novel HBV antisense RNA delivery system targeting hapatocellular carcinoma and study its inhibitory effect in vitro and in vivo. METHODS GE7,a 16-peptide specific to EGFR, and HA20,a homologue of N-terminus of haemagglutinin of influenza viral envelope protein, were synthesized and conjugated with polylysin. The above conjugates were organized into the pEBAF-as-preS2, a hepatocarcinoma specific HBV antisense expression vector, to construct a novel HBV antisense RNA delivery system, named AFP-enhancing 4-element complex. Hepatocelluar carcinoma HepG2.2.15 cells was used to assay the in vitro inhibition of the complex on HBV. Expression of HBV antigen was assayed by ELISA. BALB/c nude mice bearing HepG2.2.15 cells were injected with AFP-enhancing 4-element complex. The expression of HBV antisense RNA was examined by RT-PCR and the size of tumor in nude mice were measured. RESULTS The AFP-enhancing 4-element complex was constructed and DNA was completely trapped at the slot with no DNA migration when the ratio of polypeptide to plasmid was 1:1. The expression of HBsAg and HBeAg of HepG2.2.15 cells was greatly decreased after being transfected by AFP-enhancing 4-element complex. The inhibitory rates were 33.4 % and 58.5 % respectively. RT-PCR showed HBV antisense RNA expressed specifically in liver tumor cells of tumor-bearing nude mice. After 4 injections of AFP-enhancing 4-element complex containing 0.2 micro g DNA, the diameter of the tumor was 0.995 cm+/-0.35, which was significantly smaller than that of the control groups(2.215 cm+/-0.25, P<0.05). CONCLUSION AFP-enhancing 4-element complex could deliver HBV antisense RNA targeting on hepatocarcinoma and inhibit both HBV and liver tumor cells in vitro and in vivo.
Collapse
Affiliation(s)
- Chun-Hong Ma
- Institute of Immunology,Medical College of Shandong University, Jinan 250012, Shandong Province, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Hao CQ, Feng ZH, Zhou YX, Nie QH, Li JG, Jia ZS, Liang XS, Xie YM, Cao YZ, Kang WZ. Construction, package and identification of replication-deficient recombinant adenovirus expression vector of HCV C. Shijie Huaren Xiaohua Zazhi 2003; 11:144-147. [DOI: 10.11569/wcjd.v11.i2.144] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To construct a replication-deficient recombinant adenovirus expression vector of HCV C.
METHODS: The HCV core gene was cloned at the downstream of CMV promoter of the adenoviral shuttle plasmid pAd. CMV-link. 1, and the resultant recombinant plasmid pAd. HCV-C was cotransfected into 293 cell together with plasmid pJM17 containing adenoviral genome, then the adenovirus expression vector was obtained, and identified by infecting test, electronic microscope observation and PCR co-amplification. The plasmid pAd. HCV-C was identified by endonuclease, PCR and sequencing. The expressive activity of adenovirus vector was identified by immunofluorescence and Western blot.
RESULTS: HCV core gene in the inserted DNA of pAd. HCV-C was confirmed by endonuclease, PCR and sequencing. Results of infecting test, electronic microscopic observation and PCR co-amplification showed that the adenovirus vector had been constructed successfully. Expression of HCV core antigen was proved in the HepG2 cells by immunofluorescence and Western blot.
CONCLUSION: The replication-deficient recombinant adenovirus vector can express HCV core antigen in HepG2 cells. This study established a foundation for further study on HCV vaccines and gene therapy for hepatitis C.
Collapse
|
7
|
Xu CT, Huang LT, Pan BR. Current gene therapy for stomach carcinoma. World J Gastroenterol 2001; 7:752-9. [PMID: 11819868 PMCID: PMC4695588 DOI: 10.3748/wjg.v7.i6.752] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/20/2001] [Revised: 05/29/2001] [Accepted: 06/06/2001] [Indexed: 02/06/2023] Open
Affiliation(s)
- C T Xu
- Editorial Department, the Journal of Fourth Military Medical University, Xi'an, Shaanxi Province, China.
| | | | | |
Collapse
|
8
|
Liu DH, Zhang XY, Fan DM, Huang YX, Zhang JS, Huang WQ, Zhang YQ, Huang QS, Ma WY, Chai YB, Jin M. Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma. World J Gastroenterol 2001; 7:500-5. [PMID: 11819817 PMCID: PMC4688661 DOI: 10.3748/wjg.v7.i4.500] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2001] [Revised: 01/08/2001] [Accepted: 01/15/2001] [Indexed: 02/06/2023] Open
Abstract
AIM To establish the role of vascular endothelial growth factor (VEGF) in the oncogenesis of human gastric carcinoma more directly. METHODS The expression of VEGF and its receptor kinase-domain insert containing receptor (KDR) in human gastric cancer tissue were observed by immunohistochemical staining. VEGF levels were manipulated in human gastric cancer cell using eukaryotic expression constructs designed to express the complete VEGF(165) complimentary DNA in either the sense or antisense orientation. The biological changes of the cells were observed in which VEGF was up-regulated or down-regulated. RESULTS VEGF-positive rate was 50%, and VEGF was mainly localized in the cytoplasm and membrane of the tumor cells, while KDR was mainly located in the membrane of vascular endothelial cells in gastric cancer tissues and peri-cancerous tissue. In 2 cases of 50 specimens, the gastric cancer cells expressed KDR, localized in both the cytoplasm and membrane. Introduction of VEGF(165) antisense into human gastric cancer cells (SGC-7901, immunofluorescence intensity, 31.6%)) resulted in a significant reduction in VEGF-specific messenger RNA and total and cell surface VEGF protein (immunofluorescence intensity, 8.9%) (P<0.05). Conversely, stable integration of VEGF(165) in the sense orientation resulted in an increase in cellular and cell surface VEGF (immunofluorescence intensity, 75.4%) (P<0.05). Lowered VEGF levels were associated with a marked decrease in the growth of nude mouse xenografted tumor (at 33 days postimplantation, tumor volume: 345.40 +/- 136.31 mm3)(P<0.05 vs control SGC-7901 group: 1534.40 +/- 362.88 mm3), whereas up-regulation of VEGF resulted in increased xenografted tumor size (at 33 days postimplantation, tumor volume: 2350.50 +/- 637.70 mm3) (P<0.05 vs control SGC-7901 group). CONCLUSION This study provides direct evidence that VEGF plays an important role in the oncogenesis of human gastric cancer.
Collapse
MESH Headings
- Adult
- Aged
- Animals
- Cell Division
- Cloning, Molecular
- DNA, Antisense
- DNA, Complementary
- Endothelial Growth Factors/genetics
- Endothelium, Vascular/physiology
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Lymphokines/genetics
- Male
- Mice
- Mice, Nude
- Middle Aged
- Neovascularization, Pathologic/pathology
- Neovascularization, Pathologic/physiopathology
- Receptor Protein-Tyrosine Kinases/genetics
- Receptors, Growth Factor/genetics
- Receptors, Vascular Endothelial Growth Factor
- Stomach Neoplasms/pathology
- Stomach Neoplasms/physiopathology
- Transfection
- Tumor Cells, Cultured
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
Collapse
Affiliation(s)
- D H Liu
- Institute of Combined Injury, Third Military Medical University, Chongqing 400038, China.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Yang CQ, Wang JY, He BM, Liu JJ, Guo JS. Glyco-poly-L-lysine is better than liposomal delivery of exogenous genes to rat of liver. World J Gastroenterol 2000; 6:526-531. [PMID: 11819641 PMCID: PMC4723551 DOI: 10.3748/wjg.v6.i4.526] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To compare the effects of liposomes and glyco-poly-L-lysine on liver tar geted uptake and expression of plasmid in rat liver.
METHODS: After binding with lipofectamine or galactose-terminal glyco-poly-L-lysine, the plasmid could be expressed in eukaryotic cells when injected into Wistar rats by intravenous route. At different time intervals after the injection, the distribution and expression of the plasmid in liver of rats were observed and compared using in situ hybridization and immunohistochemistry.
RESULTS: The expression of the plasmid binding to liposomes or G-PLL could be markedly observed 24 h later, and began to decrease one week later, but it still could be observed up to three weeks. Both liposomes and G-PLL could deliver the plasmid to the liver effectively, but the effect of the latter was better than the former concerning the distribution and expression of the plasmid targeted uptake in the liver.
CONCLUSION: G-PLL is better than liposome as the targeted carrier for delivering exogenous genes to the liver.
Collapse
|
10
|
Chen B, Zhang XY, Zhang YJ, Zhou P, Gu Y, Fan DM. Antisense to cyclin D1 reverses the transformed phenotype of human gastric cancer cells. World J Gastroenterol 1999; 5:18-21. [PMID: 11819376 PMCID: PMC4688490 DOI: 10.3748/wjg.v5.i1.18] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/30/1998] [Revised: 09/14/1998] [Accepted: 10/06/1998] [Indexed: 02/06/2023] Open
Abstract
AIM:To further investigate the effect of cyclin D1 on the biologic behavior of cancer cells and its potential role in gene therapy of tumor.METHODS:A cyclin D1 subcloning plasmid termed BKSD1 was constructed by subcloning the human cyclin D1 cDNA into Bluescript-KS, a plasmid vector with a pair of T7 and T3 promoters, with recombinant DNA technology of molecular biology. So,it is easy to generate digoxigenin (DIG)-labeled RNA probes of antisense and sense to cyclin D1 using RKSD1 as a template vector. PDORD1AS, an eukaryotic expression vector containing the full-length human cyclin D1 cDNA in its antisense orientation cloned into the retroviral vector pDOR-neo, was successfully constructed with BKSD1 to change restriction sites. A gastric cancer cell line, SGC7901/VCR, was transfected with pDORD1AS by Lipofect Amine-mediated introduction and a subline termed SGC7901/VCRD1AS, which had stable overexpression of antisense RNA to cyclin D1, was obtained by selection in G418. The subline, control subline transfected pDOR-neo and SGC7901/VCR were evaluated by methods of immunohistochemistry, flow cytometry, molecular hybridization, morphology and cell biology.RESULTS:Compared with control cell lines, SGC7901/VCRD1AS had a reduced expression of cyclin D1 (inhibition rate was about 36%), increased cell size and cytoplasm to nucleus ratio, increased doubling time (42.2h to 26.8h and 26.4h), decreased saturation density (18.9X10(4) to 4.8X10(5) and 4.8X10(5)), increased percentage of cells in the G(1)/G(0) phase (80.9%-64.6% and 63.8%), reacquired serum dependence, and a loss of tumorigenicity in nude mice (0/4 to 4/4 and 4/4).CONCLUSION: Stable overexpression of antisense RNA to cyclin D1 can reverse the transformed phenotype of human gastric cancer cells and may provide an approach of gene therapy for gastric cancer.
Collapse
|
11
|
|